Jefferies Financial Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Buy
105,400
+5,500
+6% +$666K 0.07% 233
2026
Q1
$16.3M Hold
99,900
0.11% 151
2025
Q4
$17.4M Hold
99,900
0.09% 214
2025
Q3
$14.4M Hold
99,900
0.07% 177
2025
Q2
$10.1M Hold
99,900
0.08% 172
2025
Q1
$7.62M Hold
99,900
0.07% 204
2024
Q4
$6.9M Buy
99,900
+94,100
+1,622% +$6.78M 0.04% 287
2024
Q3
$423K Sell
5,800
-49,600
-90% -$3.66M ﹤0.01% 1024
2024
Q2
$3.71M Buy
55,400
+34,200
+161% +$1.33M 0.04% 378
2024
Q1
$575K Sell
21,200
-2,300
-10% -$64.4K 0.01% 1020
2023
Q4
$728K Hold
23,500
﹤0.01% 1088
2023
Q3
$593K Buy
+23,500
New +$537K 0.01% 1008

Other funds holding INSM

Jefferies Financial Group's INSM Position: Q2 2026 in Review

Jefferies Financial Group increased its Insmed (INSM) stake by 183% in Q2 2026, buying an estimated $774K and bringing the position to 9,896 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #945.

Jefferies Financial Group first reported a position in INSM in Q1 2023 and has held it in 13 quarters since. The position peaked at $161M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Jefferies Financial Group held 9,896 shares of Insmed worth $1.06M as of Q2 2026.
  • Jefferies Financial Group bought 6,396 Insmed shares in Q2 2026, an estimated $774K.
  • Insmed made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #945 holding.
  • Jefferies Financial Group first reported a position in Insmed in Q1 2023 and has held it in 13 quarters since.
  • Jefferies Financial Group's Insmed position peaked at $161M in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.